Focusing on the importance of the free phenolic hydroxyl moiety, a family of 23 alkylresorcinol-based compounds were developed and evaluated for their cannabinoid receptor binding properties. The non-symmetrical hexylresorcinol derivative 29 turned out to be a CB2-selective competitive antagonist/inverse agonist endowed with good potency. Both the olivetol- and 5-(2-methyloctan-2-yl)resorcinol-based derivatives 23 and 24 exhibited a significant antinociceptive activity. Interestingly, compound 24 proved to be able to activate both cannabinoid and TRPV1 receptors. Even if cannabinoid receptor subtype selectivity remained a goal only partially achieved, results confirm the validity of the alkylresorcinol nucleus as skeleton for the identification of potent cannabinoid receptor modulators.

Synthetic bioactive olivetol-related amides: The influence of the phenolic group in cannabinoid receptor activity / A. Brizzi, F. Aiello, S. Boccella, M.G. Cascio, L. De Petrocellis, M. Frosini, F. Gado, A. Ligresti, L. Luongo, P. Marini, C. Mugnaini, F. Pessina, F. Corelli, S. Maione, C. Manera, R.G. Pertwee, V. Di Marzo. - In: BIOORGANIC & MEDICINAL CHEMISTRY. - ISSN 0968-0896. - 28:11(2020 Jun 01), pp. 115513.1-115513.11. [10.1016/j.bmc.2020.115513]

Synthetic bioactive olivetol-related amides: The influence of the phenolic group in cannabinoid receptor activity

F. Gado;
2020

Abstract

Focusing on the importance of the free phenolic hydroxyl moiety, a family of 23 alkylresorcinol-based compounds were developed and evaluated for their cannabinoid receptor binding properties. The non-symmetrical hexylresorcinol derivative 29 turned out to be a CB2-selective competitive antagonist/inverse agonist endowed with good potency. Both the olivetol- and 5-(2-methyloctan-2-yl)resorcinol-based derivatives 23 and 24 exhibited a significant antinociceptive activity. Interestingly, compound 24 proved to be able to activate both cannabinoid and TRPV1 receptors. Even if cannabinoid receptor subtype selectivity remained a goal only partially achieved, results confirm the validity of the alkylresorcinol nucleus as skeleton for the identification of potent cannabinoid receptor modulators.
Alkylresorcinols; Antinociceptive effect; Cannabinoid ligands; Dual ligand; Endocannabinoids; Transient receptor potential vanilloid type-1 channel; Amides; Analgesics; Animals; Cell Line; Dose-Response Relationship, Drug; Humans; Male; Mice; Molecular Structure; Rats; Receptors, Cannabinoid; Resorcinols; Structure-Activity Relationship; TRPV Cation Channels
Settore CHIM/08 - Chimica Farmaceutica
1-giu-2020
Article (author)
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0968089620303394-main.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 2.64 MB
Formato Adobe PDF
2.64 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/907522
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 3
social impact